Hair samples were collected from 60 patients receiving long-term methadone maintenance: 50 were taking the drug orally and 10 were receiving the drug by intravenous injection. The amount of methadone present in the hair samples was measured using methanolic extraction, derivatization of the extracts with MTBSTFA, followed by electron impact gas chromatography-mass spectrometry operating in selected ion monitoring mode. The limit of quantitation for the assay was 0.4 ng/mg hair. The dose/concentration relationship for methadone in hair was investigated. No interindividual correlation between prescribed dose and concentration of methadone in hair was observed.
Introduction
Methadone is used in drug-treatment programs for both detoxification and for long-term maintenance therapy. It is usual to analyze urine from these patients in order to detect covert substance misuse and to prevent illicit diversion of prescribed opiates. However, the analysis of hair may be a useful alternative for verifying drug history and for monitoring compliance. Analysis of hair provides valuable information regarding long-term drug use because of its retrospective time window. In order to interpret the results of the analysis of hair, it is important to establish what the relationship is between dose given and the resulting drug concentration in hair. Various studies have been performed to investigate this relationship for methadone. The work of Marsh et al. (1) showed evidence that a relationship between the levels of methadone in hair and the prescribed dose may exist, and Moeller et al. (2) looked at eight patients and found a correlation of 0.63 for the relationship. In contrast, Girod and Staub (3) recently undertook a pilot study which included 26 patients undergoing long-term oral main-' Aulhor to whom correspondence should be addressed. E-mail: s.paterson@ic,ac.uk.
tenance therapy, but they found no relationship between administered dose and concentration in hair for methadone. The present study included 60 patients, all of whom were receiving long-term methadone maintenance; 50 were prescribed oral methadone and 10 were prescribed injectable methadone. The amount of methadone in a 3-cm sample representing approximately the previous three months growth was measured and related to the dose given.
Method
Methadone was measured by methanolic extraction followed by gas chromatography-mass spectrometry (GC-MS) using a previously described procedure (4) . In summary, samples of hair were washed twice with dichloromethane, cut into l-ram segments, and an internal standard, 10 12L of 0.1 mg/mL in methanol PCP-d5, was added prior to extraction with methanol at 45~ for 18 h. The methanol was removed, evaporated to dryness, and derivatized with 25 pL of MTBSTFA. The vials were placed in a heating block at 90~ for 1 h. After cooling, 1 IJL from each vial was injected onto the GC-MS. GC-MS analysis was performed using an HP6890 GC with an HP7683 automatic liquid sampler interfaced with an HP5973 mass selective detector operating in SIM mode. The standard curves were prepared by adding 0, 1, 2.5, 10, 15, and 25 IJL of a standard solution of methadone at 20 ng/mL to 50 mg of blank hair to give drug concentrations of 0, 0.4, 1, 4, 6, and 10 ng/mg of hair. A reagent blank was also prepared. Inter-and intra-assay reproducibility were monitored by running the same 6-ng/mg standard every 10th injection throughout each run.
Hair samples
Hair was collected from 60 patients who had been on continuous methadone maintenance treatment for between 3 and 192 months with an average of 25 months. The hair was cut as close as possible to the scalp, and the root end was carefully labelled. Measuring from the root end, 3-cm lengths were cut, representing approximately three months growth, and the exact weight was noted. The prescribed dose of methadone was determined from case notes. The daily dose each patient received remained constant for at least the three months prior to the hair sample being taken and many had been receiving the same maintenance daily dose for many months prior to this. At the time the hair sample was taken, each patient completed a volunteer consent form and a drug questionnaire. Any patient who admitted using "street methadone" in addition to his/her daily prescribed dose was omitted from the study. Each patient's drug intake was monitored throughout the three months prior to hair sampling by taking urine samples at random intervals. These samples were screened for drugs of abuse using solidphase extraction and GC-MS (5). If any patient gave a urine sample that did not contain methadone, he/she was omitted from the study on the assumption that he/she had not been compliant with their prescribed medication.
Validation data
The standard curve was linear with a correlation coefficient of regression of 0.9958 over the concentration range 0 to 10 ng/rng of hair. The limit of detection was taken as the lowest standard, 0.4 ng/mg of hair. Recovery of spiked drug from the extract was 83.9% (n = 6) with a relative standard deviation for the recoveries of 9.0%.
Results and Discussion
Figures I and 2 show graphically for each patient the dose per day of methadone and the concentration found in hair. Figure 1 shows the results for patients taking methadone orally, and Figure 2 shows the results for patients receiving methadone by intravenous injection. The correlation coefficients of linear regression, unweighted, as calculated using the Excel program on Windows 97, were 0.136 for patients receiving oral methadone and 0.0006 for those receiving methadone by intravenous injection. These results support the finding of Staub and Girod (3), which is that no relationship exists between administered dose and concentration found in hair for methadone. The data presented here show that this is irrespective of whether the methadone is administered orally or by intravenous injection. In both the oral and the injectable groups there is an "outlier".
If the correlation coefficient of linear regression (R) is calculated for the oral group excluding the value for a dose of 70 rag/day with a methadone concentration in hair of 63.2 ng/mg, then R = 0.2263, and for the injectable group excluding the value for a dose of 120 rag/day with a methadone concentration in hair of 127.5 ng/mg, then R = 0.3407. Table I shows the dose/day and the concentration of methadone found in hair for patients receiving oral methadone. 18o The dose has been divided in to three ranges, low (20-50 rag/day), medium (60-100 rag/day), and high (110-165 rag/day), in order to investigate if it is possible knowing the concentration of methadone in hair to estimate the dose range. For the low-dose group, the methadone concentration found in hair varied between 4.2 and 22.7 with a mean of 9.0 ng/mg hair, for the medium-dose groups the range was 2.6 to 63.2 with a mean of 19.7 ng/mg hair and for the high-dose group the range was 9.6 to 43.9 ng/mg hair with a mean of 19.2. The mean for the low-dose group was lower than for the medium or high groups, both of which had a similar mean, but the ranges for all three groups overlap. This means that extreme caution is needed when extrapolating from the concentration of methadone found in hair to the likely daily dose. Table II shows the dose and concentration found in hair for those patients receiving methadone by intravenous injection. The dose ranged from 100 to 200 rag/day, and the concentration found in hair ranged from 18.0 to 127.5 with a mean of 41.6 ng/mg. The mean is approximately twice the mean for the equivalent dose given orally, but again, the range overlaps with even the low oral dose.
Various reasons have been postulated for the lack of relationship between dose and concentration in hair for methadone. Kidwell et al. (6) postulated that drugs are incorporated into hair through an ion exchange mechanism with a limited number of sites available for ionic interaction. Wilkins et al. (7) suggested that pigmentation is an important factor, and Girod and Staub (3) suggested that gender and absorption of other drugs or medication may influence incorporation. It may be that some drugs, once absorbed into hair, may diffuse through the hair shaft. Although an individual hair may grow at a rate of approximately 1 cm per month, when considering a group of hairs there will be hairs at each of the various stages of growth present, that is, the anagen or growing stage, the catagen or resting stage, and the telogen or casting stage. This may influence the apparent lack of dose/concentration relationship. Drugs enter the hair by active uptake from the blood supply at the root, but they may also enter the hair from sweat and sebum once the hair has grown.
Of the 60 subjects in the study, 53 were white European, 4 from the Middle East, 1 black Caribbean, and 2 of mixed race. Although 53 were white European, there were no fair-haired people in the study, and there were 4 subjects with bleached or color-treated hair. This means that 88% of the subjects were of the same ethnic group with hair color only varying from brown to black.
There were 19 female and 41 male subjects. The correlation coefficient for oral dose versus concentration of methadone in hair for females alone was 0.0055 (or 0.0619 if the "outlier" is omitted), and for males only it was 0.3153, suggesting better correlation for dose versus concentration of methadone in hair for males than females. The poorer correlation for females may be because all four subjects with bleached or color-treated hair were female.
There were two subjects with very high methadone hair concentrations: the patient in the group receiving oral methadone was a white European female with color-treated hair, and in the group receiving methadone by injection, the patient was a white European male with dark brown hair.
As data generated from drug users may be regarded as unreliable, all reasonable steps were taken to ensure the reliability of the data in this study. The self-report questionnaire completed at the time of sampling asked for Cone. Range details of any drugs used in addition to the (ng/mg hair) prescribed daily methadone during the three Mean months prior to sampling. This information was known to the research team only, it was not passed to the patient's key worker or clinic doctor, and there were no potentially adverse consequences for the patients for answering truthfully. It has been argued that self-report data are accurate when gathered by independent researchers for epidemiological purposes (8) . In addition, the patients were monitored by the collection of urine samples randomly during the three months prior to hair sampling in order to ensure as far as was practically possible that the patients were consuming their daily dose of methadone. The number of urine samples taken varied from 3 to 13 with an average of 6. l~venty-eight patients were omitted from the study after admitting to using "street methadone" at some point during the three months prior to hair sampling, and nine subjects were eliminated for having one or more urine samples showing negative for methadone. This left a total of 60 subjects for the study.
Of the subjects receiving oral methadone, 32% attended the clinic daily to get their dose, and the remainder received takehome methadone. The correlation coefficient of linear regression for dose versus concentration of methadone in hair for those subjects not receiving take-home methadone was 0.163. All those attending the injectables clinic received take-home methadone. Take-home doses of methadone are given as a reward for compliance with treatment. However, because takehome doses of methadone are involved, there is always the possibility for non-compliance. It is known that the addict may not take the daily dose as prescribed; they may take less (ng/mg hair) Mean (n = 10) 41.6
during the week and more on the weekend. If they are having a bad day, they are known to take more and vice versa. The possibility that some of their take-home medication may be diverted cannot be ruled out.
In conclusion, analysis of hair for the presence of methadone can be used to provide data for verifying a verbal drug history and in confirming treatment compliance, but no realistic estimate can be made of the prescribed dose. Further studies would be required to discover whether intraindividual methadone concentrations in hair will yield clinically useful data.
